Indian man tests COVID-19 positive after stolen protective suit from hospital, thinking it is raincoat

An injured drunken man admitted to a hospital in India allegedly stole an used personal protective equipment (PPE) kit, thinking that it was a raincoat, and later tested positive for COVID-19 infection.
August 05, 2020 | 07:18
strict regulations applied admist the coronavirus outbreak Strict regulations applied admist the coronavirus outbreak
another flight carries citizens home from canada rok local spread widens Another flight carries citizens home from Canada, RoK; local spread widens
ministry of public security 177 illegal chinese immigrants uncovered since june Ministry of Public Security: 177 illegal Chinese immigrants uncovered since June
indian man tests covid 19 positive after stolen protective suit from hospital thinking it is raincoat
Representative image. Photo Credit: ANI

According to Times Now, the man makes a living by selling vegetables. Last week, he got injured after falling into a drain while returning home as he was heavily drunk. He then was rushed to a nearby hospital for initial treatment and was later shifted to a hospital in Nagpur, northeastern Maharashtra state, western India.

It was at the hospital that he came across a PPE kit and stole it, thinking it was a raincoat. When he went home, he showed it to everyone saying it was a raincoat he had bought for 1,000 rupees (about USD 13.32).

People around him grew suspicious and it was soon discovered that it was indeed a PPE kit. Local authorities were alerted, who recovered the item and burned it.

Subsequently, the man's samples were collected for a COVID-19 test which came out positive. The man's family and everyone who came into contact with him, including his family members, relatives and friends, were also tested for the virus. Thankfully, all of them were found negative for the infection, according to a report by Sakal Times.

Twitter users are sharing news reports after his tests returned positive for the novel coronavirus.

indian man tests covid 19 positive after stolen protective suit from hospital thinking it is raincoat
Shortages of protective health gear in India are forcing some doctors to use raincoats and motorbike helmets while fighting the coronavirus. A doctor wearing a torn raincoat stands at the major coronavirus disease treatment facility in Kolkata, India, March 26, 2020. REUTERS/Stringer

Bizarre incidents have been galore during the coronavirus pandemic.

In May, more than 20 people regarding an abduction in India, including the family of the man who kidnapped the 18-month-old toddler, policemen, and two journalists, have been sent to quarantine, after the kidnapper and rescued boy both tested coronavirus positive.

When contacted, police officials told Indian Express that before being produced in the court, the 27-year-old accused was made to undergo medical tests, including for COVID-19, and he tested positive for the virus. Following that, the kidnapped boy was also tested and he too turned out to be COVID-19 positive.

Race to COVID-19 drugs

Global coronavirus cases have crossed 18.3 million, resulting in close to 694,000 deaths. India has a caseload of over 1.8 million, the third biggest, behind the United States and Brazil.

India's Sun Pharmaceutical Industries Ltd said on August 4 it would soon begin selling its version of favipiravir, becoming the latest generic drugmaker to supply the antiviral to treat COVID-19 in the world's third worst-hit nation, reported Reuters.

Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in India, which saw a surge of 50,000-plus infections for the sixth straight day on August 4.

Sun's version of favipiravir, to be called FluGuard, will cost 35 rupees (USD 0.47) per 200 mg tablet, making it the cheapest version available. Stocks will be available from this week.

Favipiravir was originally developed by Japan's Fujifilm Holdings Corp as Avigan. Once hyped as a potential COVID-19 treatment, Avigan was dampened by clinical studies.

Still, Indian regulators gave emergency approval to favipiravir in June in an effort to tackle the "urgent and unmet" need for COVID-19 treatments in the country.

Separately, another Indian drugmaker, Jubilant Life Sciences Ltd, on August 3 announced the launch of its version of remdesivir, priced at 4,700 rupees per 100 mg vial. Jubilant is among the companies producing the drug under licence from US-based Gilead Sciences Inc./.

106 year old indian delhi man who was child during spanish flu survives covid 19 106-year-old Indian Delhi man who was child during Spanish Flu survives Covid-19

Notably, his wife and another family member also had contracted COVID-19, and have successfully recovered about a month-and-a-half ago.

weird covid 19 style indian man wears gold face mask to shield from coronavirus Weird Covid-19 style: Indian man wears gold face mask to shield from coronavirus

Shankar Kurhade, a businessman living in Pune city, western India spent around US $4,000 for his tailor-made gold face mask, which he wears every time ...

insights from indian journalist on the success of vietnam in fight against covid 19 Insights from Indian journalist on the success of Vietnam in the fight against COVID-19

A recent article in The Times of India explained the reasons why Vietnam can manage both the COVID-19 and the economy during the pandemic.

Hannah Nguyen
Phiên bản di động